Follicum Competitors and Similar CompaniesClear all

Follicum's competitors and similar companies include MannKind Corporation, Pila Pharma and Kadimastem.
Follicum
Follicum
Follicum is a company focused on the stimulation of hair growth and diabetes.
MannKind Corporation
MannKind Corporation
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
Pila Pharma
Pila Pharma
Pila Pharma is a clinical-stage pharmaceutical company.
Kadimastem
Kadimastem
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
Founding Date
Founding Date
2011
Founding Date
1991
Founding Date
2014
Founding Date
2009
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Lund, SE HQ
Locations
Westlake Village, US HQ
Danbury, US
Locations
Malmö, SE HQ
Locations
Ness Ziona, IL HQ
Employees
Employees
N/A
Employees
39513% increase
Employees
9
Employees
11

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$349m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$26.8m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
kr357k (FY, 2021)
Gross profit
$322.2m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(kr24.2m) (FY, 2021)
Net income
$5.9m (FY, 2025)
Net income
N/A
Net income
(₪26.6m) (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

MannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase

MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.

View company
Pila Pharma
HQ
Malmö, SE
Employees
9

Pila Pharma is a clinical-stage pharmaceutical company.

View company
Kadimastem
HQ
Ness Ziona, IL
Employees
11

Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).

View company